ArticlePloS one2026
Using GDACS to anticipate clinical and operational burden after earthquakes: A global event-level analysis (2020-2024).
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global Disaster Alert and Coordination System (GDACS) alerts are widely used after earthquakes, yet their clinical relevance is uncertain. We performed a retrospective, global, event-level study spanning 2020-2024. To avoid double counting, alerts were clustered into country-bounded representatives using a 48-hour gap, retaining the alert with the highest GDACS score (n = 85; Red = 17, Orange = 68). Primary outcomes were reported deaths and field-hospital deployment. Associations used Spearman correlation; deployment was modeled with Firth logistic regression. Sensitivity analyses used alternative deployment definitions and composite windows. The GDACS score correlated with deaths (ρ = 0.522, p = 3.0 × 10 ⁻ ⁷). Field-hospital deployment occurred in 52.9% of Red events and 0% of Orange events. The GDACS score strongly predicted deployment (OR=42.7, 95% CI 4.7-385.7), with AUC = 0.98 and Brier = 0.034. An exploratory exposure-normalized subset where GDACS reported population "within 100 km" (n = 19) showed directionally consistent results (ρ = 0.50, p = 0.029).GDACS metrics provide early, scalable indicators for surge planning, but are hazard- and exposure-centric and cannot capture mediators such as collapse dynamics or health-system resilience. Treating GDACS as a first-layer signal, complemented by subnational exposure and rapid damage assessment, can support more timely, evidence-based medical response after major earthquakes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.